Huang Shumin, He Jing, Zhang Yiting, Su Lin, Tong Lin, Sun Ying, Zhou Mingming, Chen Zhimin
Department of Pulmonology, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, 310052, People's Republic of China.
National Clinical Research Center for Child Health, National Children's Regional Medical Center, Hangzhou, 310052, People's Republic of China.
Infect Drug Resist. 2022 Jul 12;15:3657-3668. doi: 10.2147/IDR.S370755. eCollection 2022.
This study aimed to investigate the biofilm-forming ability, molecular typing, and antimicrobial resistance of community-acquired methicillin-resistant (CA-MRSA) strains isolated from the respiratory tract of children and their correlation with clinical characteristics.
All CA-MRSA strains were isolated from hospitalized children, and their presentation, molecular typing, antimicrobial susceptibility, and biofilm formation were investigated. The clinical characteristics were compared between the strong and weak biofilm producer groups.
Fifty-three CA-MRSA strains were isolated from the respiratory samples of 53 children, with nearly half of them being young infants (0-12 months). Approximately, 88.7% (47/53) of the isolates were resistant to four or more antibiotics, mainly β-lactam antibiotics, lincosamides, and macrolides. Twelve sequence types (STs) and 20 subtypes of staphylococcal protein A (spa) typing were identified, with ST59-t437 (39.6%, 21/53) as the predominant subtype. All strains showed the ability to form biofilms. When compared to children with weak biofilm-forming CA-MRSA strains, those with strong biofilm-forming strains had higher proportions of lower respiratory tract infections (LRTI) (88.5% vs 59.3%), obvious cough symptoms (84.6% vs 51.9%), and severe chest imaging manifestations (76.9% vs 37.0%). Furthermore, a strong biofilm-forming ability significantly increased the risk of prolonged cough in children with LRTI (44.4% vs 14.3%), and a positive correlation between the duration of cough and the extent of biofilm formation was observed. Medical history investigation revealed that the strong biofilm-forming group had a much higher percentage of macrolides intake than the weak biofilm-forming group in the last month before admission (61.5% vs 14.8%).
ST59-t437 was the most prevalent clone in CA-MRSA respiratory isolates among the hospitalized children. All CA-MRSA strains formed biofilms. The stronger the biofilm-forming ability, the more serious and prolonged were the respiratory symptoms.
本研究旨在调查从儿童呼吸道分离出的社区获得性耐甲氧西林金黄色葡萄球菌(CA-MRSA)菌株的生物膜形成能力、分子分型和抗菌药物耐药性,以及它们与临床特征的相关性。
所有CA-MRSA菌株均从住院儿童中分离得到,对其临床表现、分子分型、抗菌药物敏感性和生物膜形成情况进行调查。比较生物膜形成能力强和弱的两组患儿的临床特征。
从53名儿童的呼吸道样本中分离出53株CA-MRSA菌株,其中近一半为小婴儿(0-12个月)。大约88.7%(47/53)的分离株对四种或更多种抗生素耐药,主要是β-内酰胺类抗生素、林可酰胺类和大环内酯类。鉴定出12种序列类型(STs)和20种葡萄球菌蛋白A(spa)分型亚型,其中ST59-t437(39.6%,21/53)为主要亚型。所有菌株均表现出形成生物膜的能力。与生物膜形成能力弱的CA-MRSA菌株患儿相比,生物膜形成能力强的患儿下呼吸道感染(LRTI)比例更高(分别为88.5%和59.3%)、咳嗽症状明显(分别为84.6%和51.9%)、胸部影像学表现严重(分别为76.9%和37.0%)。此外,生物膜形成能力强显著增加了LRTI患儿咳嗽持续时间延长的风险(分别为44.4%和14.3%),且观察到咳嗽持续时间与生物膜形成程度呈正相关。病史调查显示,生物膜形成能力强的组在入院前最后一个月服用大环内酯类药物的比例远高于生物膜形成能力弱的组(分别为61.5%和14.8%)。
ST59-t437是住院儿童CA-MRSA呼吸道分离株中最常见的克隆型。所有CA-MRSA菌株均能形成生物膜。生物膜形成能力越强,呼吸道症状越严重且持续时间越长。